Pharmacokinetic Study of Benralizumab in Healthy Chinese Subjects

Clinical trial NCT03928262 · COMPLETED

Trial details

NCT number: NCT03928262
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subjects

Start date: 2019-04-02
Primary completion: 2019-08-12
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.